(2013) FDA limits use of tolvaptan due to liver injury risk. Reactions Weekly, 1452 (1) 3 doi:10.1007/s40278-013-3072-3
Reference Type | Journal (article/letter/editorial) | ||
---|---|---|---|
Title | FDA limits use of tolvaptan due to liver injury risk | ||
Journal | Reactions Weekly | ||
Year | 2013 (May) | Volume | 1452 |
Issue | 1 | ||
Publisher | Springer Science and Business Media LLC | ||
DOI | doi:10.1007/s40278-013-3072-3Search in ResearchGate | ||
Generate Citation Formats | |||
Mindat Ref. ID | 13302650 | Long-form Identifier | mindat:1:5:13302650:6 |
GUID | 0 | ||
Full Reference | (2013) FDA limits use of tolvaptan due to liver injury risk. Reactions Weekly, 1452 (1) 3 doi:10.1007/s40278-013-3072-3 | ||
Plain Text | (2013) FDA limits use of tolvaptan due to liver injury risk. Reactions Weekly, 1452 (1) 3 doi:10.1007/s40278-013-3072-3 | ||
In | (2013, May) Reactions Weekly Vol. 1452 (1) Springer Science and Business Media LLC |
See Also
These are possibly similar items as determined by title/reference text matching only.
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |